MANA RBM Expands Remote Trial Management With TransPerfect’s Trial Interactive E-Clinical Platform

NEW YORK, April 14, 2020 /PRNewswire/ — TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that MANA RBM has selected TransPerfect’s Trial Interactive eISF, eTMF, and GlobalLearn compliance-focused learning management system (LMS) to complement its remote clinical trial solution.

MANA RBM is a Denver-based clinical trials institute and research laboratory and pioneer in the implementation of complete remote trial management solutions, including risk-based monitoring that adheres to current FDA, EMA, and ICH guidance and regulations. Their science-driven oversight provides immediate identification and corrects the systematic errors that matter most to a trial. Over nearly a decade, MANA RBM has leveraged technology solutions to develop the infrastructure for the data and document collection required for remote paperless trials.

Trial Interactive was selected to enable the inclusion of eISFs for all research sites in clinical trials large and small. The interoperability between Trial Interactive’s eISF, eTMF, and LMS solutions enables full visibility into all documents needed to remotely oversee a trial, centralizing essential documents and certified copies of source documents while securing protected health information. Sites can even upload and generate certified electronic copies of documents to align with ICH recommendations and US law—all with a few clicks of the mouse.

The Trial Interactive e-clinical platform was designed by clinical professionals, for clinical professionals. It is used by pharmaceutical, biotechnology, and CRO companies to streamline product development lifecycles in a secure 21 CFR Part 11 compliant environment. A fully interoperable author-to-archive enterprise experience, Trial Interactive improves speed and quality across site identification, site selection, personnel training, study start-up, and site activation, through eTMF management and closeout. The Trial Interactive platform delivers nuanced, clinical research–focused products that simplify tasks, oversight, compliance, and audits/inspections.

“In today’s world every sponsor needs the capability for a complete remote approach to trial conduct, including document collection and management. Trial Interactive has helped us enable a critical piece of remote trial management: visibility into all documents needed to remotely oversee a clinical trial,” said Penelope Manasco, MD, CEO of MANA RBM. “We only touch documents once because documents flow seamlessly between GlobalLearn, the eISF, and the eTMF. With Trial Interactive, we help studies lower risk and achieve near real-time oversight, without site visits.”

TransPerfect President and CEO Phil Shawe stated, “TransPerfect and MANA RBM are aligned in our commitment to delivering the most innovative solutions to our clients. Trial Interactive reduces risk and improves efficiency. We’re pleased to bring these advantages to MANA RBM and assist them in their mission to provide customers with the best remote trial management and risk-based monitoring solutions.”

About Trial Interactive
TransPerfect’s Trial Interactive is an industry leader in practical e-clinical innovation that simplifies and automates clinical processes for sponsors, CROs, and sites around the world. The 21 CFR Part 11 compliant unified platform delivers an author-to-archive collaboration experience with solutions for clinical document management, site selection, site activation, e-learning, compliance training, quality, and more with seamless solution interoperability and indexing to the eTMF. Trial Interactive is consistently selected by clinical professionals for providing the most comprehensive yet intuitive experience with the most complete offering of technology and expert TMF services. Trial Interactive helps study teams streamline their operations by cutting unnecessary expenses, expediting timelines, reducing compliance risks, and improving operational excellence. For more information on Trial Interactive, please contact info@trialinteractive.com or +1 212.400.8848, or visit www.trialinteractive.com.

About TransPerfect
TransPerfect is the world’s largest provider of language and technology solutions for global business. From offices in over 100 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. More than 5,000 global organizations employ TransPerfect’s GlobalLink® Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at www.transperfect.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/mana-rbm-expands-remote-trial-management-with-transperfects-trial-interactive-e-clinical-platform-301040377.html

SOURCE TransPerfect

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

2 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

3 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

3 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

3 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

3 hours ago